236 related articles for article (PubMed ID: 25089799)
1. Bcl3 regulates pro-survival and pro-inflammatory gene expression in cutaneous T-cell lymphoma.
Chang TP; Vancurova I
Biochim Biophys Acta; 2014 Nov; 1843(11):2620-30. PubMed ID: 25089799
[TBL] [Abstract][Full Text] [Related]
2. Bortezomib inhibits expression of TGF-β1, IL-10, and CXCR4, resulting in decreased survival and migration of cutaneous T cell lymphoma cells.
Chang TP; Poltoratsky V; Vancurova I
J Immunol; 2015 Mar; 194(6):2942-53. PubMed ID: 25681335
[TBL] [Abstract][Full Text] [Related]
3. Bortezomib induces nuclear translocation of IκBα resulting in gene-specific suppression of NF-κB--dependent transcription and induction of apoptosis in CTCL.
Juvekar A; Manna S; Ramaswami S; Chang TP; Vu HY; Ghosh CC; Celiker MY; Vancurova I
Mol Cancer Res; 2011 Feb; 9(2):183-94. PubMed ID: 21224428
[TBL] [Abstract][Full Text] [Related]
4. Analysis of TGFβ1 and IL-10 transcriptional regulation in CTCL cells by chromatin immunoprecipitation.
Chang TP; Kim M; Vancurova I
Methods Mol Biol; 2014; 1172():329-41. PubMed ID: 24908319
[TBL] [Abstract][Full Text] [Related]
5. NFκB function and regulation in cutaneous T-cell lymphoma.
Chang TP; Vancurova I
Am J Cancer Res; 2013 Nov; 3(5):433-45. PubMed ID: 24224122
[TBL] [Abstract][Full Text] [Related]
6. Down-regulating constitutive activation of the NF-kappaB canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis.
Sors A; Jean-Louis F; Pellet C; Laroche L; Dubertret L; Courtois G; Bachelez H; Michel L
Blood; 2006 Mar; 107(6):2354-63. PubMed ID: 16219794
[TBL] [Abstract][Full Text] [Related]
7. PAK1 overexpression promotes cell proliferation in cutaneous T cell lymphoma via suppression of PUMA and p21.
Wang Y; Gu X; Li W; Zhang Q; Zhang C
J Dermatol Sci; 2018 Apr; 90(1):60-67. PubMed ID: 29307600
[TBL] [Abstract][Full Text] [Related]
8. Chromatin immunoprecipitation analysis of bortezomib-mediated inhibition of NFκB recruitment to IL-1β and TNFα gene promoters in human macrophages.
Sanacora S; Chang TP; Vancurova I
Methods Mol Biol; 2014; 1172():315-27. PubMed ID: 24908318
[TBL] [Abstract][Full Text] [Related]
9. The proto-oncogene Bcl3 induces immune checkpoint PD-L1 expression, mediating proliferation of ovarian cancer cells.
Zou Y; Uddin MM; Padmanabhan S; Zhu Y; Bu P; Vancura A; Vancurova I
J Biol Chem; 2018 Oct; 293(40):15483-15496. PubMed ID: 30135206
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-9 regulates NF-kappaB activity through BCL3 gene induction.
Richard M; Louahed J; Demoulin JB; Renauld JC
Blood; 1999 Jun; 93(12):4318-27. PubMed ID: 10361130
[TBL] [Abstract][Full Text] [Related]
11. BCL3 Reduces the Sterile Inflammatory Response in Pancreatic and Biliary Tissues.
Song L; Wörmann S; Ai J; Neuhöfer P; Lesina M; Diakopoulos KN; Ruess D; Treiber M; Witt H; Bassermann F; Halangk W; Steiner JM; Esposito I; Rosendahl J; Schmid RM; Riemann M; Algül H
Gastroenterology; 2016 Feb; 150(2):499-512.e20. PubMed ID: 26526716
[TBL] [Abstract][Full Text] [Related]
12. BCL3 is induced by IL-6 via Stat3 binding to intronic enhancer HS4 and represses its own transcription.
Brocke-Heidrich K; Ge B; Cvijic H; Pfeifer G; Löffler D; Henze C; McKeithan TW; Horn F
Oncogene; 2006 Nov; 25(55):7297-304. PubMed ID: 16732314
[TBL] [Abstract][Full Text] [Related]
13. Constitutive expression of NF-kappa B is a characteristic feature of mycosis fungoides: implications for apoptosis resistance and pathogenesis.
Izban KF; Ergin M; Qin JZ; Martinez RL; Pooley RJ JR; Saeed S; Alkan S
Hum Pathol; 2000 Dec; 31(12):1482-90. PubMed ID: 11150373
[TBL] [Abstract][Full Text] [Related]
14. Suppression of Bcl3 Disrupts Viability of Breast Cancer Cells through Both p53-Dependent and p53-Independent Mechanisms via Loss of NF-κB Signalling.
Turnham DJ; Smith H; Clarkson RWE
Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38255248
[TBL] [Abstract][Full Text] [Related]
15. Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in cutaneous T cell lymphoma.
Heider U; Rademacher J; Lamottke B; Mieth M; Moebs M; von Metzler I; Assaf C; Sezer O
Eur J Haematol; 2009 Jun; 82(6):440-9. PubMed ID: 19220424
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of IkappaB kinase subunit 2 in cutaneous T-cell lymphoma down-regulates nuclear factor-kappaB constitutive activation, induces cell death, and potentiates the apoptotic response to antineoplastic chemotherapeutic agents.
Sors A; Jean-Louis F; Bégué E; Parmentier L; Dubertret L; Dreano M; Courtois G; Bachelez H; Michel L
Clin Cancer Res; 2008 Feb; 14(3):901-11. PubMed ID: 18245554
[TBL] [Abstract][Full Text] [Related]
17. Impaired Bcl3 up-regulation leads to enhanced lipopolysaccharide-induced interleukin (IL)-23P19 gene expression in IL-10(-/-) mice.
Mühlbauer M; Chilton PM; Mitchell TC; Jobin C
J Biol Chem; 2008 May; 283(21):14182-9. PubMed ID: 18375954
[TBL] [Abstract][Full Text] [Related]
18. Embelin inhibits viability of cutaneous T cell lymphoma cell lines HuT78 and H9 by targeting inhibitors of apoptosis.
Abdulrahman N; Leo R; Boumenar HA; Ahmad F; Mateo JM; Jochebeth A; Al-Sowaidi NK; Sher G; Ansari AW; Alam M; Uddin S; Ahmad A; Steinhoff M; Buddenkotte J
Leuk Lymphoma; 2023 Dec; 64(14):2236-2248. PubMed ID: 37708450
[TBL] [Abstract][Full Text] [Related]
19. Diverse effects of BCL3 phosphorylation on its modulation of NF-kappaB p52 homodimer binding to DNA.
Bundy DL; McKeithan TW
J Biol Chem; 1997 Dec; 272(52):33132-9. PubMed ID: 9407099
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
